Atlas Trials

Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC

Clinical trial NCT02473536 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02473536
Sponsor
University of Texas Southwestern Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2015-06-01
Primary completion
2027-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.